$1.17 Billion is the total value of Logos Global Management LP's 59 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 97.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALXO | Buy | ALX ONCOLOGY HLDGS INC | $272,132,000 | +129.9% | 3,156,981 | +0.6% | 23.33% | +54.0% |
| OLMA | New | OLEMA PHARMACEUTICALS INC | $180,006,000 | – | 3,743,875 | +100.0% | 15.43% | – |
| NKTX | Sell | NKARTA INC | $103,406,000 | +68.0% | 1,682,178 | -17.8% | 8.86% | +12.6% |
| FMTX | Buy | FORMA THERAPEUTICS HLDGS INC | $48,860,000 | -16.4% | 1,400,000 | +19.3% | 4.19% | -44.0% |
| TGTX | Sell | TG THERAPEUTICS INC | $44,217,000 | -5.6% | 850,000 | -51.4% | 3.79% | -36.7% |
| DYN | DYNE THERAPEUTICS INC | $33,692,000 | +4.0% | 1,604,392 | 0.0% | 2.89% | -30.3% | |
| ATHA | Sell | ATHIRA PHARMA INC | $32,465,000 | +72.3% | 947,873 | -7.1% | 2.78% | +15.4% |
| KROS | Sell | KEROS THERAPEUTICS INC | $31,743,000 | -48.6% | 450,000 | -71.9% | 2.72% | -65.5% |
| RPTX | Sell | REPARE THERAPEUTICS INC | $23,217,000 | -22.8% | 676,894 | -30.7% | 1.99% | -48.3% |
| KNTE | New | KINNATE BIOPHARMA INC | $22,659,000 | – | 569,602 | +100.0% | 1.94% | – |
| COGT | New | COGENT BIOSCIENCES INC | $21,567,000 | – | 1,920,500 | +100.0% | 1.85% | – |
| BTAI | Sell | BIOXCEL THERAPEUTICS INC | $19,866,000 | -16.7% | 430,000 | -21.8% | 1.70% | -44.2% |
| APLS | New | APELLIS PHARMACEUTICALS INC | $17,160,000 | – | 300,000 | +100.0% | 1.47% | – |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO Lcall | $17,142,000 | – | 200,000 | +100.0% | 1.47% | – |
| RNA | Sell | AVIDITY BIOSCIENCES INC | $17,136,000 | -15.6% | 671,454 | -6.9% | 1.47% | -43.5% |
| ALGS | New | ALIGOS THERAPEUTICS INC | $16,771,000 | – | 606,548 | +100.0% | 1.44% | – |
| CCCC | New | C4 THERAPEUTICS INC | $15,834,000 | – | 477,928 | +100.0% | 1.36% | – |
| LRMR | Buy | LARIMAR THERAPEUTICS INC | $15,308,000 | +205.8% | 715,000 | +116.7% | 1.31% | +104.7% |
| CMPS | Sell | COMPASS PATHWAYS PLCsponsored ads | $14,292,000 | -18.1% | 300,000 | -40.0% | 1.22% | -45.1% |
| SBTX | New | SILVERBACK THERAPEUTICS INC | $13,902,000 | – | 300,000 | +100.0% | 1.19% | – |
| IGMS | New | IGM BIOSCIENCES INC | $13,244,000 | – | 150,000 | +100.0% | 1.14% | – |
| KRTX | New | KARUNA THERAPEUTICS INC | $12,191,000 | – | 120,000 | +100.0% | 1.04% | – |
| ABCL | New | ABCELLERA BIOLOGICS INC | $12,072,000 | – | 300,000 | +100.0% | 1.04% | – |
| MRTX | New | MIRATI THERAPEUTICS INC | $10,982,000 | – | 50,000 | +100.0% | 0.94% | – |
| CALT | Sell | CALLIDITAS THERAPEUTICS ABsponsered ads | $10,086,000 | -23.6% | 300,000 | -45.5% | 0.86% | -48.8% |
| CRIS | New | CURIS INC | $9,828,000 | – | 1,200,000 | +100.0% | 0.84% | – |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $9,305,000 | +146.4% | 490,000 | +63.3% | 0.80% | +65.2% |
| MGEN | New | MIRAGEN THERAPEUTICS INC | $9,048,000 | – | 550,000 | +100.0% | 0.78% | – |
| PASG | PASSAGE BIO INC | $8,807,000 | +95.0% | 344,438 | 0.0% | 0.76% | +30.6% | |
| VINCU | New | VINCERA PHARMA INCunit 12/24/2025 | $7,704,000 | – | 400,000 | +100.0% | 0.66% | – |
| NRIX | Sell | NURIX THERAPEUTICS INC | $7,572,000 | -21.1% | 230,297 | -16.3% | 0.65% | -47.2% |
| RACA | THERAPEUTICS ACQUISITION COR | $6,960,000 | -3.2% | 500,000 | 0.0% | 0.60% | -35.1% | |
| KYMR | Sell | KYMERA THERAPEUTICS INC | $6,877,000 | -29.3% | 110,920 | -63.1% | 0.59% | -52.6% |
| EPIX | New | ESSA PHARMA INC | $6,562,000 | – | 550,000 | +100.0% | 0.56% | – |
| STTK | New | SHATTUCK LABS INC | $6,371,000 | – | 121,562 | +100.0% | 0.55% | – |
| PMVP | Sell | PMV PHARMACEUTICALS INC | $6,151,000 | +15.5% | 100,000 | -33.3% | 0.53% | -22.6% |
| LUNG | New | PULMONX CORP | $5,177,000 | – | 75,000 | +100.0% | 0.44% | – |
| EYPT | New | EYEPOINT PHARMACEUTICALS INC | $4,606,000 | – | 699,999 | +100.0% | 0.40% | – |
| ANNX | ANNEXON INC | $3,995,000 | -17.2% | 159,622 | 0.0% | 0.34% | -44.6% | |
| BDTX | BLACK DIAMOND THERAPEUTICS I | $3,957,000 | +6.0% | 123,465 | 0.0% | 0.34% | -29.1% | |
| HSAQ | HEALTH SCIENCES ACQ CORP 2 | $3,843,000 | +16.5% | 300,000 | 0.0% | 0.33% | -22.0% | |
| PCVX | New | VAXCYTE INC | $3,720,000 | – | 140,000 | +100.0% | 0.32% | – |
| HRMY | Sell | HARMONY BIOSCIENCES HLDGS IN | $3,615,000 | -61.2% | 100,000 | -63.6% | 0.31% | -74.0% |
| BMYRT | Sell | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $3,485,000 | -71.8% | 5,050,000 | -8.2% | 0.30% | -81.1% |
| NVUS | New | NOVUS THERAPEUTICS INC | $3,451,000 | – | 224,071 | +100.0% | 0.30% | – |
| ITOS | Sell | ITEOS THERAPEUTICS INC | $3,382,000 | -54.3% | 100,000 | -66.7% | 0.29% | -69.4% |
| OM | Sell | OUTSET MED INC | $2,842,000 | -43.2% | 50,000 | -50.0% | 0.24% | -61.9% |
| PANAU | PANACEA ACQUISITION CORPunit 99/99/9999 | $2,552,000 | +6.3% | 200,000 | 0.0% | 0.22% | -28.7% | |
| BCTG | BCTG ACQUISITION CORP | $2,288,000 | +10.4% | 200,000 | 0.0% | 0.20% | -26.0% | |
| HLXA | New | HELIX ACQUISITION CORP | $2,274,000 | – | 200,000 | +100.0% | 0.20% | – |
| EAR | New | EARGO INC | $2,241,000 | – | 50,000 | +100.0% | 0.19% | – |
| OPT | New | OPTHEA LTDsponsored ads | $1,794,000 | – | 160,000 | +100.0% | 0.15% | – |
| PLRX | Sell | PLIANT THERAPEUTICS INC | $1,736,000 | -43.9% | 76,426 | -44.1% | 0.15% | -62.4% |
| TVTX | New | TRAVERE THERAPEUTICS INC | $1,667,000 | – | 61,152 | +100.0% | 0.14% | – |
| CERE | New | CEREVEL THERAPEUTICS HLDNG I | $1,658,000 | – | 100,000 | +100.0% | 0.14% | – |
| AMTI | New | APPLIED MOLECULAR TRANS INC | $1,318,000 | – | 42,847 | +100.0% | 0.11% | – |
| FSDC | FS DEV CORP | $1,100,000 | -1.8% | 100,000 | 0.0% | 0.09% | -34.3% | |
| GBIO | New | GENERATION BIO CO | $482,000 | – | 17,000 | +100.0% | 0.04% | – |
| CEREW | New | CEREVEL THERAPEUTICS HLDNG I*w exp 06/09/202 | $188,000 | – | 33,333 | +100.0% | 0.02% | – |
| RAPT | Exit | RAPT THERAPEUTICS INC | $0 | – | -31,100 | -100.0% | -0.13% | – |
| ARYBU | Exit | ARYA SCIENCES ACQUISTION COunit 06/09/2027 | $0 | – | -100,000 | -100.0% | -0.14% | – |
| CHAQU | Exit | CHARDAN HEALTHCR ACQSTN 2 COunit 99/99/9999 | $0 | – | -200,000 | -100.0% | -0.27% | – |
| AFIB | Exit | ACUTUS MED INC | $0 | – | -75,000 | -100.0% | -0.29% | – |
| NARI | Exit | INARI MED INC | $0 | – | -50,000 | -100.0% | -0.44% | – |
| RLAY | Exit | RELAY THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.54% | – |
| PAND | Exit | PANDION THERAPEUTICS INC | $0 | – | -450,000 | -100.0% | -0.66% | – |
| LSACU | Exit | LIFESCI ACQUISITION CORPunit 03/31/2025 | $0 | – | -400,000 | -100.0% | -0.70% | – |
| INBX | Exit | INHIBRX INC | $0 | – | -311,578 | -100.0% | -0.72% | – |
| UMRX | Exit | UNUM THERAPEUTICS INC | $0 | – | -2,700,000 | -100.0% | -0.81% | – |
| AKUS | Exit | AKOUOS INC | $0 | – | -310,000 | -100.0% | -0.91% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -250,000 | -100.0% | -1.96% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -750,000 | -100.0% | -2.08% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEW | $0 | – | -1,200,000 | -100.0% | -2.28% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -275,000 | -100.0% | -4.94% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -850,000 | -100.0% | -6.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 14 | Q3 2023 | 12.6% |
| KARUNA THERAPEUTICS INC | 14 | Q3 2023 | 5.6% |
| ALX ONCOLOGY HLDGS INC | 13 | Q3 2023 | 23.3% |
| DYNE THERAPEUTICS INC | 13 | Q3 2023 | 4.9% |
| APELLIS PHARMACEUTICALS INC | 12 | Q3 2023 | 12.4% |
| OLEMA PHARMACEUTICALS INC | 12 | Q3 2023 | 15.4% |
| DESIGN THERAPEUTICS INC | 11 | Q3 2023 | 8.0% |
| NUVATION BIO INC | 11 | Q3 2023 | 0.0% |
| BICYCLE THERAPEUTICS PLC | 10 | Q2 2023 | 5.7% |
| IDEAYA BIOSCIENCES INC | 9 | Q3 2023 | 9.5% |
View Logos Global Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | July 18, 2023 | 6,350,000 | 8.1% |
| BICYCLE THERAPEUTICS plc | February 14, 2023 | 1,435,000 | 4.8% |
| Dyne Therapeutics, Inc. | February 14, 2023 | 2,150,000 | 4.1% |
| Design Therapeutics, Inc. | March 31, 2022 | 2,797,501 | 5.0% |
| IDEAYA Biosciences, Inc. | March 18, 2022 | 2,650,000 | 6.9% |
| Aligos Therapeutics, Inc. | February 14, 2022 | ? | ? |
| Cogent Biosciences, Inc. | February 14, 2022 | 150,000 | 0.4% |
| Kezar Life Sciences, Inc. | February 14, 2022 | 1,450,000 | 3.0% |
| Nkarta, Inc. | February 14, 2022 | ? | ? |
| Viridian Therapeutics, Inc.\DE | February 14, 2022 | ? | ? |
View Logos Global Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-01 |
| SC 13G | 2024-02-22 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G | 2024-01-22 |
| SC 13G | 2024-01-22 |
| SC 13G | 2024-01-02 |
View Logos Global Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.